In this episode, Sarah McGoldrick, Executive Director of Finance at Singing River Health System, joins the podcast to discuss evolving payer changes and their impact on the revenue cycle. She also shares insights on opportunities for growth and the introduction of GLP-1 medications and their implications for healthcare organizations.
Sarah McGoldrick, Executive Director of Finance at Singing River Health System
Next Up in Becker's CFO + Revenue Cycle Podcast
-
In this episode, Jon Alford, CFO of UW Medicine and Vice President for Medical Affairs at the University of Washington,…
-
In this episode, Stacey A. Rizza, MD, Medical Director for Global Commercial Solutions at Mayo Clinic International, joins the podcast…
-
In this episode, Dan Shields, Chief Executive Officer, Digital Medicine, Ochsner Health, discusses scaling digital medicine, using AI responsibly, redesigning…
Comments are closed.